Recent events
Recent events tied to this brand in public sources.
Back to profile12 entries
2026
Quest Diagnostics discloses patient data breach
Quest Diagnostics disclosed that a cyberattack involving its Quanum lab-testing system resulted in unauthorized access to certain patient records and that some patients’ protected health information was taken. The amount and specific kinds of data affected were not specified; Quest said it was investigating.
2026
Quest Diagnostics discloses unauthorized access to patient records
Quest Diagnostics disclosed that an unauthorized party accessed certain patient records in its Quanum Lab Services Manager system. The company said it was investigating the incident and had not determined the full scope.
2022
Quest Diagnostics launches at-home rapid antigen test service
Quest Diagnostics announced the availability of an at-home COVID-19 rapid antigen test service for consumers through QuestDirect. The service includes proctored telehealth through eMed, and Quest said it was collaborating with Truepill for order fulfillment and delivery.
2021
Quest Diagnostics acquires Labtech Diagnostics assets
Quest Diagnostics announced that it had acquired substantially all assets of Labtech Diagnostics, a clinical diagnostic laboratory provider serving patients and physicians primarily in South Carolina, North Carolina, Georgia and Florida.
2021
Quest Diagnostics completes integration at Clifton laboratory
Quest Diagnostics completed the integration of its Northeast regional operations into a new 250,000-square-foot laboratory facility in Clifton, New Jersey, which it said serves more than 40 million people per year across seven states.
2021
Carnival Corporation partners with Quest Diagnostics on pre-cruise testing
Carnival Corporation & plc partnered with Quest Diagnostics to provide pre-cruise COVID-19 testing appointments to guests booked on any Carnival brand, with access to more than 1,500 Quest patient service centers and retail pharmacy testing locations across the United States.
2021
Quest Diagnostics sued over workers’ compensation billing
A plaintiff sued Quest Diagnostics, alleging that it directly billed a patient for workers’ compensation-related charges despite notice that the charges were work-related and authorization from the workers’ compensation insurer. The complaint alleges a violation of Florida’s Consumer Collection Practices Act.
2021
IQVIA acquires Quest Diagnostics’ Q2 Solutions stake
IQVIA acquired Quest Diagnostics’ 40 percent minority share of Q2 Solutions for $760 million, resulting in IQVIA owning 100 percent. Quest Diagnostics was to remain Q2 Solutions clients’ strategic preferred laboratory provider under a multi-year agreement.
2020
FDA authorizes Quest COVID-19 test for pooled samples
The FDA reissued an emergency use authorization allowing Quest Diagnostics to use its COVID-19 test with pooled samples. The reports describe it as the first test authorized for this use.
2020
Quest Diagnostics announces consumer COVID-19 antibody testing
Quest Diagnostics announced that consumers could request and purchase its on-demand COVID-19 antibody test online, subject to physician review. The test cost $119.
2020
Quest Diagnostics announces plan to acquire Blueprint Genetics
Quest Diagnostics said it would acquire Helsinki-based Blueprint Genetics in an all-cash deal. The companies said the deal would enable them to serve providers specializing in rare diseases and neurology in pediatric and academic hospitals.
2020
Quest Diagnostics acquires Blueprint Genetics
Quest Diagnostics announced that it had acquired Blueprint Genetics in an all-cash equity transaction. Blueprint Genetics was expected to continue operating largely independently from its Helsinki base laboratory.